Par Pharmaceutical Up 100.8% Since SmarTrend's Buy Recommendation
Do you know when to trade PRX ?
PRX | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called an Uptrend for Par Pharmaceutical (NYSE:PRX) on March 24, 2009 at $11.03.
Since then, Par Pharmaceutical has returned 100.8% as of today's recent price of $22.15. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
For full details on Par Pharmaceutical Co Inc (PRX) PRX. Par Pharmaceutical Co Inc (PRX) has Short Term PowerRatings at TradingMarkets. Details on Par Pharmaceutical Co Inc (PRX) Short Term PowerRatings is available at This Link.
- Protox completes private placement - 03/16/10
- Protox revises terms of private placement - 02/25/10
- Par Pharmaceutical Bearish Moving Average Crossover Alert (PRX) - 02/25/10
- Protox to present at the Third International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer - 02/24/10
- Par Pharmaceutical Companies Reports Adjusted EPS of $0.65 for Fourth Quarter 2009 - 02/24/10
- More News >>


